Commentary

Nulla eu felis ligula. Nulla porttitor sapien auctor odio lobortis sagittis. Nulla facilisi. Etiam aliquet arcu ac tempor luctus. Nunc eleifend mi faucibus tellus maximus, sed auctor turpis faucibus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Integer quis velit vel erat maximus feugiat nec vitae lacus. Nulla facilisi.

Sed quis vestibulum mauris. Fusce varius cursus est, ac auctor lorem rutrum sit amet. Suspendisse vel lacus eget libero auctor aliquam at nec sapien. Donec auctor, neque in tincidunt mollis, quam leo sagittis nisl, a tempor velit nunc at dui. Morbi malesuada sit amet ligula vel euismod. Cras porttitor orci non justo imperdiet vulputate. Morbi in nibh pretium, finibus augue rhoncus, pulvinar lectus. Nunc sollicitudin tempor volutpat.

Dave Banister, Chief Strategist, Themarketanalysts.com The markets remain a bit extended but we also just had a nice 3 week consolidation in the SP 500 and could still work up to my 3996 Major 5 target over next several weeks. There are plenty of money supply...

TBIO 22.88 Avg net entry around 15-15.50 Closing this out as Vaccine stocks are losing luster, this may do very well long term.  That said, we sold 1/3 for 75-80% gains at 27.50 a few weeks ago, now closing out to make room for new 1st quarter...

Today I am doing some quick updates on our 9 portfolio names , I plan to have 3 more with 12 being the max. Each position should be about 8% of a TPS allocation portfolio. Obviously I weight this in smaller cap names and Biotech in...

BIVI near $12 as of 12/14/20 close Recent IPO in late September at $10 Max Entry 13, add  all the way to 11.50 on near term dips Liver treatment indication that is de-risked and a potential promising Alzheimers indication added to pipeline in 2021 Target in...

indian xxnx horny desi indian cheating slime wife show boobs in webcam.